Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|September 11, 2013
Animal toxicity of hairpin pyrrole-imidazole polyamides varies with the turn unitFei Yang, Nicholas G Nickols, Benjamin C Li, et al.
Advances in Radiation Oncology|May 6, 2022
Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric ComparisonTrudy C Wu, Michael Xiang, Nicholas G Nickols, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2012
Single-dose pharmacokinetic and toxicity analysis of pyrrole-imidazole polyamides in miceTimothy W Synold, Bixin Xi, Jun Wu, et al.
Cancers|February 13, 2026
The Optimal Management of Patients with Prostate Cancer with Oligometastatic Disease and Low Metastatic Burden in the PSMA-PET EraMenal Bhandari, Isaac Lasko, Jacob Pozin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2023
Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized TrialJack Neylon, Ting Martin Ma, Ricky Savjani, et al.
European Urology Focus|January 2, 2021
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical OutcomeJeremie Calais, Wesley R Armstrong, Amar U Kishan, et al.
Clinical Advances in Hematology & Oncology : H&O|August 30, 2023
Selecting the optimal radiation modality in prostate cancerLuca F Valle, Amar U Kishan, Antonio Franco, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective studyMasatoshi Hotta, Kathleen Nguyen, Pan Thin, et al.
BMC Cancer|May 8, 2021
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocolJeremie Calais, Shaojun Zhu, Nader Hirmas, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2022
Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRTNathanael Kane, Tahmineh Romero, Silvia Diaz-Perez, et al.
Pageof 13